|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||13.65 - 14.01|
|52-week range||13.65 - 14.01|
|Beta (5Y monthly)||0.61|
|PE ratio (TTM)||N/A|
|Earnings date||09 Feb 2022 - 14 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Investors need to pay close attention to Anavex (AVXL) stock based on the movements in the options market lately.
With the business potentially at an important milestone, we thought we'd take a closer look at Anavex Life Sciences...
With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer. Following management's remarks, there will be a question-and-answer session.